Transduced DCs were then pulsed with the HLA-A*0201-restricted melanoma tumor-associated antigen MART-1 and used to stimulate MART-1-specific CD8+ tumor-infiltrating lymphocytes (TIL). Here, HLA-A is linked to neoplasm.